dan 2163 has been researched along with Body Weight in 6 studies
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We have assessed the evolution of body weight and glycaemia during a 6-month randomized comparative trial of amisulpride and olanzapine." | 9.12 | Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine. ( De Hert, M; Mortimer, A; Peuskens, J, 2007) |
| "To compare the efficacy and safety of the atypical antipsychotics amisulpride and olanzapine in the treatment of acute psychotic exacerbations of schizophrenia." | 9.10 | A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months. ( Fleurot, O; Giudicelli, A; Lĵo, H; Martin, S; Peuskens, J; Rein, W; Thirumalai, S, 2002) |
| "Amisulpride, a substituted benzamide with high selectivity for dopamine D3 and D2 receptors, was compared with the antipsychotic risperidone in patients with acute exacerbations of schizophrenia." | 9.09 | Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group. ( Bale, R; Bech, P; Fleurot, O; Möller, HJ; Peuskens, J; Rein, W, 1999) |
| " We conducted a prospective, open study in schizophrenia patients in order to compare body weight and serum lipids during treatment with amisulpride, ziprasidone, clozapine or olanzapine over a period of 4 weeks." | 5.12 | Early changes of plasma lipids during treatment with atypical antipsychotics. ( Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA, 2006) |
| " We have assessed the evolution of body weight and glycaemia during a 6-month randomized comparative trial of amisulpride and olanzapine." | 5.12 | Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine. ( De Hert, M; Mortimer, A; Peuskens, J, 2007) |
| "To compare the efficacy and safety of the atypical antipsychotics amisulpride and olanzapine in the treatment of acute psychotic exacerbations of schizophrenia." | 5.10 | A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months. ( Fleurot, O; Giudicelli, A; Lĵo, H; Martin, S; Peuskens, J; Rein, W; Thirumalai, S, 2002) |
| "Amisulpride, a substituted benzamide with high selectivity for dopamine D3 and D2 receptors, was compared with the antipsychotic risperidone in patients with acute exacerbations of schizophrenia." | 5.09 | Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group. ( Bale, R; Bech, P; Fleurot, O; Möller, HJ; Peuskens, J; Rein, W, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, CC | 1 |
| Bai, YM | 1 |
| Wang, YC | 1 |
| Chen, TT | 1 |
| Lai, IC | 1 |
| Chen, JY | 1 |
| Chen, SY | 1 |
| Gau, SS | 1 |
| Liou, YJ | 1 |
| Martin, S | 1 |
| Lĵo, H | 1 |
| Peuskens, J | 3 |
| Thirumalai, S | 1 |
| Giudicelli, A | 1 |
| Fleurot, O | 2 |
| Rein, W | 2 |
| Zink, M | 1 |
| Knopf, U | 1 |
| Henn, FA | 1 |
| Thome, J | 1 |
| Rettenbacher, MA | 1 |
| Ebenbichler, C | 1 |
| Hofer, A | 1 |
| Kemmler, G | 1 |
| Baumgartner, S | 1 |
| Edlinger, M | 1 |
| Hummer, M | 1 |
| Lechleitner, M | 1 |
| Fleischhacker, WW | 1 |
| De Hert, M | 1 |
| Mortimer, A | 1 |
| Bech, P | 1 |
| Möller, HJ | 1 |
| Bale, R | 1 |
1 review available for dan 2163 and Body Weight
| Article | Year |
|---|---|
Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Topics: Adult; Amisulpride; Antipsychotic Agents; Body Weight; Clozapine; Dose-Response Relationship, Drug; | 2004 |
4 trials available for dan 2163 and Body Weight
| Article | Year |
|---|---|
A double-blind, randomised comparative trial of amisulpride versus olanzapine in the treatment of schizophrenia: short-term results at two months.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; B | 2002 |
Early changes of plasma lipids during treatment with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; B | 2006 |
Metabolic control in patients with schizophrenia treated with amisulpride or olanzapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Mass Index; Body Weig | 2007 |
Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Body Weight; Double-Blind Method; Female; H | 1999 |
1 other study available for dan 2163 and Body Weight
| Article | Year |
|---|---|
Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Body Weight; Energy Metabolism; Female; Follow-Up Studies; | 2009 |